point
past
year
denv
move
asian
jungl
rural
villag
still
transmit
human
peridomest
mosquito
albopictu
migrat
peopl
commerc
ultim
move
virus
larger
villag
town
citi
tropic
asia
virus
like
transmit
sporad
albopictu
possibl
close
relat
peridomest
stegomyia
speci
halstead
slave
trade
result
commerc
respons
introduct
widespread
distribut
african
mosquito
dengu
viru
emerg
reemerg
viral
pathogen
dengu
viru
emerg
reemerg
viral
pathogen
dengu
viru
emerg
reemerg
viral
pathogen
dengu
viru
emerg
reemerg
viral
pathogen
dengu
viru
emerg
reemerg
viral
pathogen
dengu
viru
emerg
reemerg
viral
pathogen
dengu
virus
denv
form
dengu
complex
genu
flaviviru
famili
flavivirida
consist
four
antigen
relat
distinct
denv
serotyp
denv
caus
spectrum
ill
rang
asymptomat
dengu
infect
dengu
fever
df
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
estim
close
billion
risk
million
infect
million
symptomat
among
million
symptomat
case
million
end
sever
form
infect
dhf
dss
around
fatal
case
occur
annual
around
world
infect
occur
develop
underdevelop
countri
surveil
network
infecti
diseas
robust
mean
possibl
gross
underreport
dengu
chapter
discuss
evolut
viru
vector
epidemiolog
dengu
molecular
genom
structur
denv
pathogenesi
immun
respons
host
infect
laboratori
diagnosi
manag
recent
develop
dengu
drug
vaccin
develop
four
denv
origin
serotyp
similar
natur
histori
includ
enzoot
cycl
involv
nonhuman
primat
canopydwel
mosquito
asia
urban
cycl
involv
human
primari
vertebr
host
aed
mosquito
subgenu
stegomyia
primari
mosquito
vector
global
topic
author
specul
african
origin
subsequ
distribut
around
world
slave
trade
ehrenkranz
et
al
smith
also
propos
virus
may
origin
forest
cycl
involv
lower
primat
canopydwel
mosquito
malay
peninsula
halstead
smith
recent
studi
base
sequenc
data
dengu
flavivirus
suggest
african
origin
progenitor
flaviviru
ultim
branch
three
genera
flaviviru
pestiviru
hepaciviru
denv
belong
genu
flaviviru
branch
four
subgroup
insectspecif
virus
isol
variou
mosquito
speci
vertebr
virus
known
arthropod
vector
isol
rodent
bat
mosquitoborn
virus
tickborn
virus
cook
et
al
crabtre
et
al
kuno
et
al
uzcategui
et
al
seem
plausibl
ancestr
flaviviru
mosquito
tick
viru
diverg
adapt
varieti
vertebr
host
includ
rodent
bird
bat
nonhuman
primat
tickborn
mosquitoborn
virus
common
ancestor
support
fact
sever
mosquitoborn
flavivirus
mbfv
koutango
saboya
west
nile
yellow
fever
yf
isol
tick
attoui
et
al
also
report
tickborn
virus
replic
mosquito
mosquito
cell
cultur
clifford
et
al
known
whether
diverg
four
flaviviru
subgroup
occur
africa
asia
area
asian
origin
denv
support
ecolog
phylogenet
evid
vasilaki
et
al
thu
four
dengu
serotyp
document
sylvat
cycl
involv
nonhuman
primat
arbor
mosquito
malay
peninsula
marchett
et
al
wherea
document
similar
cycl
africa
robert
et
al
data
collect
suggest
denv
like
evolv
virus
mosquito
becom
adapt
lower
primat
human
estim
year
ago
moncayo
et
al
wang
et
al
denv
highli
adapt
mosquito
host
maintain
vertic
transmiss
mosquito
speci
respons
sylvat
cycl
period
amplif
lower
primat
hotta
kimura
first
isol
viru
intracrani
inocul
serum
acut
ill
patient
suckl
mice
hotta
hotta
sabin
et
al
similarli
isol
virus
us
soldier
station
india
new
guinea
hawaii
sabin
schlesing
viru
strain
three
geograph
locat
antigen
similar
viru
call
dengu
sever
isol
anoth
antigen
distinct
viru
strain
new
guinea
call
dengu
two
serotyp
dengu
dengu
subsequ
isol
patient
hemorrhag
diseas
epidem
manila
philippin
hammon
et
al
recent
isol
malaysia
howev
may
increas
dengu
complex
five
serotyp
normil
aed
aegypti
like
african
origin
follow
reason
first
close
relat
stegomyia
speci
america
wherea
numer
speci
subgenu
ethiopian
orient
region
second
aegypti
occur
africa
widespread
feral
speci
breed
forest
independ
human
primarili
urban
speci
region
rare
occur
absenc
man
current
think
aegypti
african
origin
adapt
peridomest
environ
breed
water
storag
contain
west
african
villag
prior
slave
trade
provid
mechan
speci
introduc
new
world
aegypti
alreadi
becom
establish
mani
larg
tropic
cite
around
world
especi
port
citi
asia
new
world
aegypti
becom
predomin
stegomyia
speci
mani
noncoast
citi
second
world
war
smith
clear
speci
strictli
limit
latitud
rare
persist
time
beyond
n
centuri
aegypti
commonli
expand
geograph
distribut
northern
southern
latitud
warm
summer
month
breed
store
water
contain
aboard
river
boat
ship
mean
transport
ultim
infest
northern
citi
north
america
europ
frequent
transmit
epidem
dengu
yf
kuno
winter
month
speci
would
disappear
area
januari
juli
isotherm
c
northern
southern
latitud
respect
secondari
mosquito
vector
human
infect
includ
aed
albopictu
like
origin
epidem
vector
denv
smith
asian
mosquito
predomin
daybit
stegomyia
speci
asian
villag
citi
second
world
war
denv
transmit
sylvat
cycl
asia
africa
princip
sylvat
cycl
occur
malay
peninsula
four
serotyp
transmit
nonhuman
primat
speci
aed
finlaya
niveu
complex
marchett
et
al
aegypti
new
world
like
centuri
speci
becam
highli
adapt
human
urban
environ
ultim
spread
throughout
tropic
ship
industri
speci
like
first
infest
port
citi
move
inland
urban
expand
gubler
first
report
major
epidem
ill
compat
thought
possibl
dengu
publish
jin
dynasti
encyclopedia
formal
edit
ce
sui
dynasti
ce
northern
sung
dynasti
diseas
call
water
poison
chines
thought
somehow
connect
fli
insect
associ
water
gubler
uncertain
epidem
batavia
jakarta
indonesia
cairo
egypt
dengu
serolog
studi
identifi
predomin
viru
philippin
greec
south
pacif
halstead
papaevangel
simmon
rosen
serotyp
also
caus
major
region
epidem
occur
pacif
asia
second
world
war
hotta
kuno
sabin
schlesing
particular
viru
serotyp
persist
geograph
region
sever
year
emerg
period
caus
epidem
herd
immun
human
popul
wane
new
epidem
strain
viru
emerg
support
recent
studi
shown
singl
serotyp
genotyp
remain
domin
countri
caus
period
epidem
long
year
gubler
also
document
viru
subtyp
persist
urban
commun
silent
transmiss
caus
mild
nonspecif
febril
ill
recogn
dengu
gubler
et
al
yoon
et
al
like
origin
word
dengu
swahili
epidem
denguelik
ill
zanzibar
east
african
coast
diseas
call
kidinga
pepo
meant
diseas
character
sudden
cramplik
seizur
caus
evil
spirit
epidem
cuba
ill
first
call
dunga
later
call
dengu
name
known
ever
sinc
gubler
document
yf
transmit
mosquito
reed
et
al
mani
earli
worker
suspect
df
also
mosquitoborn
diseas
first
document
mosquito
could
transmit
df
graham
work
follow
show
conclus
aegypti
could
transmit
diseas
volunt
follow
incub
period
mosquito
fed
person
acut
ill
df
diseas
dengu
consid
major
public
health
problem
first
place
led
polici
chang
redirect
resourc
decay
public
health
infrastructur
deal
infecti
diseas
gener
vectorborn
diseas
particular
gubler
gubler
gubler
gubler
addit
lack
polit
success
mosquito
control
program
replac
emerg
respons
program
reli
hightechnolog
outdoor
space
spray
nonresidu
insecticid
although
popular
polit
program
never
effect
interrupt
transmiss
usual
initi
late
geograph
limit
area
moreov
insecticid
reach
target
adult
aegypti
rest
seclud
place
insid
hous
gubler
failur
control
mosquito
vector
dengu
unfortun
coincid
period
dramat
urban
growth
global
chang
lifestyl
contribut
problem
water
storag
practic
citi
water
suppli
unreli
use
nonbiodegrad
contain
packag
consum
good
rapidli
grow
automobil
industri
water
storag
contain
plastic
use
automobil
truck
tyre
provid
ideal
oviposit
site
larval
habitat
aegypti
mosquito
gubler
mosquito
control
effort
sinc
earli
direct
toward
adult
mosquito
use
expens
method
ineffect
chang
lifestyl
provid
increasingli
larval
habitat
result
larg
mosquito
popul
crowd
human
popul
live
intim
contact
increas
dengu
transmiss
urban
growth
dramat
sinc
earli
driven
primarili
econom
expans
citi
tropic
develop
countri
explod
million
suscept
peopl
migrat
rural
area
gubler
global
urban
popul
estim
billion
peopl
current
popul
cross
billion
project
billion
peopl
live
urban
area
econom
growth
also
princip
driver
global
intercontinent
travel
pose
major
risk
pandem
spread
pathogen
illustr
recent
spread
dengu
influenza
sever
acut
respiratori
syndrom
sar
coronavirus
gubler
era
major
citi
tropic
world
crowd
human
popul
effect
mosquito
control
hyperendem
multipl
denv
serotyp
cocircul
denv
fulli
adapt
human
longer
requir
sylvat
cycl
surviv
gubler
larg
crowd
tropic
citi
world
modern
airport
provid
perfect
environ
mainten
propag
spread
dengu
diseas
dfdhf
import
arbovir
diseas
human
occur
major
tropic
area
world
billion
peopl
live
area
risk
infect
estim
million
infect
million
symptomat
case
dengu
includ
million
case
dhf
death
rang
occur
annual
bhatt
et
al
casefat
rate
dhf
averag
world
health
organ
estim
death
year
bhattacharya
et
al
estim
lifetim
number
infect
per
person
southeast
asia
estim
overal
annual
infect
rate
annual
infect
rate
among
children
among
adult
current
global
pandem
dfdhf
began
asia
second
world
war
virus
mosquito
vector
aegypti
spread
wide
throughout
region
halstead
war
exist
water
system
destroy
water
store
domest
use
well
fire
control
militari
equip
junk
left
behind
make
ideal
larval
habitat
aegypti
movement
equip
war
activ
result
transport
mosquito
egg
new
geograph
area
guzman
et
al
result
greatli
expand
geograph
distribut
increas
densiti
aegypti
increas
epidem
dengu
activ
bhatia
et
al
econom
expans
drive
forc
unpreced
urban
growth
continu
today
ferreira
hous
water
sewer
wast
manag
inadequ
vector
popul
thu
increas
dramat
crowd
unhygien
citi
asia
mosquito
control
measur
effect
econom
expans
also
led
increas
movement
peopl
along
virus
also
move
among
citi
countri
region
countri
alreadi
hyperendem
rapidli
becam
hyperendem
gubler
first
record
epidem
occur
manila
philippin
follow
anoth
also
manila
third
epidem
bangkok
hammon
et
al
diseas
caus
outbreak
india
malaysia
singapor
vietnam
indonesia
myanmar
present
time
dramat
geograph
expans
epidem
dhf
countri
asia
pacif
america
bhatia
et
al
japan
routin
experienc
dengu
epidem
southern
island
okinawa
formosa
taiwan
japanes
mainland
affect
second
world
war
hotta
follow
second
world
war
isol
pacif
result
disappear
denv
area
year
late
explos
epidem
df
caus
moreau
et
al
reintroduc
pacif
asia
rapidli
spread
throughout
island
pattern
similar
kuberski
et
al
also
introduc
asia
spread
similar
fashion
first
report
df
australia
late
although
aegypti
probabl
never
erad
northern
queensland
combin
improv
water
system
control
program
reduc
popul
low
level
dengu
transmiss
report
absenc
year
dengu
reappear
northern
queensland
caus
outbreak
sever
citi
kay
et
al
america
evid
dengu
epidem
quiescenc
due
sever
factor
import
aegypti
erad
program
pan
america
health
organ
aim
reduc
yf
outbreak
gubler
erad
program
discontinu
earli
urban
epidem
dengu
yf
longer
problem
failur
erad
aegypti
whole
region
howev
result
repeat
reinvas
mosquito
countri
achiev
erad
support
mosquito
surveil
control
program
wane
end
decad
mani
countri
reinfest
aegypti
gubler
aegypti
distribut
similar
erad
initi
bermuda
chile
remain
free
mosquito
characterist
dengu
america
earli
hypoendem
singl
serotyp
present
one
time
countri
gubler
thu
reinvas
central
south
america
aegypti
combin
increas
urban
movement
peopl
denv
mosquito
vector
spread
via
commerc
result
countri
evolv
nonendem
virus
present
hypoendem
one
viru
present
hyperendem
multipl
viru
serotyp
present
et
al
surveil
dengu
africa
except
poor
centuri
endem
transmiss
document
nigeria
report
epidem
df
increas
dramat
sinc
outbreak
occur
east
west
africa
amarasingh
et
al
summar
current
dengu
pandem
origin
southeast
asia
follow
second
world
war
postwar
year
dhf
syndrom
first
describ
sever
diseas
sporad
local
southeast
asian
countri
howev
diseas
began
spread
first
within
asia
pacif
tropic
america
due
factor
lack
polit
success
mosquito
control
program
replac
emerg
respons
program
reli
hightechnolog
outdoor
space
spray
nonresidu
insecticid
although
popular
polit
program
never
effect
interrupt
transmiss
usual
initi
late
geograph
limit
area
moreov
insecticid
reach
target
adult
aegypti
rest
seclud
place
insid
hous
gubler
murray
et
al
failur
control
mosquito
vector
dengu
unfortun
coincid
period
dramat
urban
growth
global
chang
lifestyl
contribut
problem
water
storag
practic
citi
water
suppli
unreli
use
nonbiodegrad
contain
packag
consum
good
rapidli
grow
automobil
industri
water
storag
contain
plastic
use
automobil
truck
tyre
provid
ideal
oviposit
site
larval
habitat
aegypti
mosquito
mosquito
control
effort
sinc
earli
direct
toward
adult
mosquito
use
expens
method
ineffect
chang
lifestyl
provid
increasingli
larval
habitat
result
larg
mosquito
popul
crowd
human
popul
live
intim
contact
increas
dengu
transmiss
banerje
et
al
fig
dengu
repres
substanti
econom
diseas
burden
commun
health
system
endem
countri
increas
report
case
sinc
earli
factor
contribut
increas
incid
dengu
includ
follow
rise
global
commerc
tourism
popul
growth
rapid
urban
inadequ
water
sewer
wast
manag
system
inadequ
vector
control
polici
shepard
et
al
expans
dengu
pose
seriou
econom
diseas
burden
countri
across
world
econom
burden
estim
dengu
critic
provid
policymak
research
develop
drug
vaccin
manufactur
donor
reliabl
compar
measur
inform
decis
health
polici
research
health
servic
prioriti
diseas
burden
refer
impact
diseas
mortal
morbid
popul
repres
disabilityadjust
life
year
dali
nonmonetari
index
estim
person
year
life
lost
due
prematur
mortal
econom
burden
dengu
three
main
compon
ill
cost
cost
directli
relat
diseas
surveil
control
cost
cost
relat
dengu
surveil
vector
control
prevent
activ
cost
harder
measur
encompass
effect
season
cluster
dengu
health
system
decreas
tourism
dengu
outbreak
shepard
et
al
comorbid
complic
associ
dengu
infect
davi
bourk
laoprasopwattana
et
al
seet
et
al
will
et
al
econom
cost
dengu
estim
total
number
dengu
episod
time
unit
cost
per
episod
surveil
system
countri
passiv
depend
case
present
healthcar
system
passiv
surveil
system
adequ
monitor
gener
trend
dengu
infect
promptli
detect
dengu
outbreak
usual
underreport
total
episod
symptomat
dengu
common
limit
passiv
surveil
system
includ
variat
definit
report
dengu
misdiagnosi
dengu
episod
unrecogn
dengu
symptom
misinterpret
diagnost
test
relianc
report
healthcar
profession
laboratori
staff
limit
surveil
budget
variabl
report
rate
inpati
outpati
set
public
privat
facil
epidem
nonepidem
cycl
beatti
et
al
gubler
kuno
siqueira
et
al
direct
unit
cost
includ
direct
medic
cost
diagnost
test
drug
medic
medic
personnel
salari
fring
benefit
nonmed
cost
includ
cost
transport
lodg
food
main
sourc
indirect
cost
dengu
worktim
loss
ie
product
loss
caus
disabl
case
death
resourc
time
spent
patient
caregiv
also
includ
nonmed
direct
indirect
unit
cost
dengu
shepard
et
al
unfortun
studi
estim
econom
diseas
burden
dengu
region
area
uncertainti
measur
econom
loss
associ
dengu
first
estim
total
episod
dengu
difficult
due
pauciti
data
second
evid
suggest
rate
underreport
vari
sever
dengu
better
report
sever
case
dengu
duart
franca
third
estim
econom
cost
dengu
includ
febril
day
subsequ
critic
phase
dengu
total
day
lum
et
al
suaya
et
al
dengu
lead
substanti
reduct
patient
qualiti
life
febril
period
last
consider
uncertainti
burden
dengu
larg
part
world
includ
western
pacif
south
asia
africa
sever
report
dengu
outbreak
occur
region
mani
countri
surveil
system
monitor
report
dengu
episod
lack
accur
identif
method
anoth
area
uncertainti
includ
popul
healthseek
behavior
multipl
site
treatment
privat
treat
patient
modest
rate
report
near
nil
report
patient
seek
altern
method
treatment
pharmaci
tradit
medicin
suaya
et
al
current
effect
dengu
vaccin
specif
antivir
treatment
dengu
way
prevent
control
spread
dengu
infect
suppress
vector
popul
activ
vector
control
system
base
strong
activ
surveil
system
gubler
clark
surveil
earli
detect
dengu
case
first
line
defens
potenti
epidem
guid
health
agenc
respons
optim
use
scarc
resourc
focus
infect
area
gener
invalu
inform
health
provid
policymak
guzman
et
al
cost
dengu
vector
control
surveil
encompass
follow
cost
surveil
cleanup
campaign
fumig
inspect
educ
gener
public
tradit
dengu
control
strategi
focu
reduc
mosquito
abund
reduc
adult
mosquito
life
span
prevent
contact
sourc
reduct
locat
destruct
mosquito
breed
site
use
larvicid
control
juvenil
mosquito
life
stage
occur
water
use
ultravolum
aerosol
adulticid
control
adult
mosquito
bali
et
al
massad
coutinho
howev
integr
vector
manag
recommend
strategi
vectorborn
diseas
includ
dengu
strategi
involv
social
mobil
environment
manag
epidemiolog
entomolog
surveil
chemic
biolog
control
tapiacony
et
al
howev
due
budget
constraint
compet
prioriti
effect
mosquito
control
weak
dengueendem
countri
tapiacony
et
al
result
crisi
mental
focus
implement
emerg
control
method
respons
epidem
gubler
vector
control
current
intervent
dengu
howev
ineffect
vector
control
program
allow
spread
aed
mosquito
speci
dengu
ill
communitybas
dengu
control
program
alon
combin
control
activ
enhanc
effect
dengu
control
program
heintz
et
al
addit
insecticid
resist
challeng
lead
failur
dengu
control
program
complic
control
activ
increas
magnitud
futur
dengu
epidem
econom
analysi
dengu
control
technolog
develop
geneticsbas
steril
insect
method
infect
mosquito
wolbachia
vaccin
import
guid
invest
technolog
polici
formul
adapt
adopt
technolog
therebi
mitig
econom
burden
dengu
ill
futur
luz
et
al
anoth
technolog
might
prove
effect
human
dengu
vaccin
immun
costeffect
us
per
dali
avert
compar
us
per
dali
avert
vector
control
adult
aegypti
us
per
dali
immun
case
manag
environment
controlal
cost
shepard
et
al
analysi
conclud
vaccin
avail
costeffect
polici
addit
much
favor
us
per
dali
save
environment
manag
zeng
et
al
increment
costeffect
ratio
dengu
vaccin
southeast
asia
estim
us
per
dali
save
us
compar
favor
public
health
program
children
cost
averag
us
per
dali
save
us
shepard
et
al
econom
burden
dengu
absenc
effect
vaccin
cohort
us
per
popul
per
year
due
dhf
situat
highest
incid
dhf
lower
vaccin
price
public
sector
make
vaccin
costeffect
shepard
et
al
drug
would
help
reduc
symptom
possibl
mortal
would
valuabl
complementari
tool
reduc
health
econom
burden
dengu
research
test
sever
antivir
drug
latest
publish
resultslik
earlier
oneshav
prove
disappoint
notabl
advanc
recent
year
although
need
therapeut
agent
would
reduc
effect
prevent
measur
vaccin
vector
control
develop
implement
remain
need
demand
still
substanti
quantif
econom
burden
contribut
toward
better
decis
current
promis
new
prevent
cur
approach
reduc
burden
dengu
shepard
et
al
flavivirus
form
welldefin
genu
base
share
antigen
genet
properti
mani
flavivirus
import
human
pathogen
zoonot
addit
dengu
denv
genu
contain
yf
viru
yfv
japanes
enceph
viru
west
nile
viru
wnv
tickborn
enceph
virus
flaviviru
genu
classifi
famili
flavivirida
share
two
recogn
genera
pestiviru
hepaciviru
newli
propos
genu
consist
g
barker
viru
gbv
isol
famili
defin
similar
morpholog
genom
organ
replic
although
genu
distinct
antigen
biolog
properti
genu
flaviviru
offici
divid
intern
committe
taxonomi
virus
ictv
serogroup
consist
formal
recogn
speci
report
virus
wyli
et
al
exampl
dengu
serotyp
consid
singl
speci
even
though
genet
antigen
quit
distinct
similar
geograph
distribut
hostvector
associ
diseas
syndrom
flavivirida
spheric
envelop
virus
singleprotein
capsid
two
three
membran
protein
two
flavivirus
envelop
membran
singlestrand
positivesens
ribonucl
acid
rna
genom
lack
poli
tail
end
flavivirida
genom
singl
open
read
frame
orf
translat
singl
complet
polyprotein
rna
helicas
rnadepend
rna
polymeras
rdrp
orf
flank
two
noncod
region
flaviviru
genom
kb
length
code
region
flavivirus
includ
follow
order
three
structur
gene
encod
protein
capsid
c
precursor
membran
prm
cleav
membran
protein
matur
envelop
e
seven
nonstructur
ns
gene
encod
form
proteas
also
helicas
rna
triphosphatas
activ
rdrp
also
methyltransferas
activ
bennett
flaviviru
genom
rna
serv
viral
messeng
rna
translat
complet
polyprotein
begin
first
second
aug
codon
orf
polyprotein
cleav
conserv
site
either
viral
serin
proteas
hostderiv
signalas
except
prm
cleav
assembl
hostderiv
furin
furinlik
proteas
flaviviru
replic
ensu
cytoplasm
host
endoplasm
reticular
er
membran
modifi
vesicular
packet
replic
probabl
occur
fulllength
complementari
negativesens
rna
strand
produc
serv
templat
positivesens
genom
copi
flaviviru
assembl
viru
particl
probabl
occur
rough
er
rer
acquir
membran
viru
particl
matur
pass
host
secretori
system
exocytosi
pathway
cleavag
prm
eventu
bud
host
cell
interestingli
virion
may
releas
coat
mixtur
matur
cleav
immatur
uncleav
mprm
protein
flavivirus
defin
antigen
related
among
thing
exhibit
variou
degre
crossreact
profil
serolog
test
mansfield
et
al
flavivirus
first
group
togeth
group
b
arbovirus
base
crossspeci
hemagglutin
inhibit
hi
later
divid
eight
serocomplex
compris
virus
basi
crossneutr
test
calish
et
al
serocomplex
correspond
amino
acid
distanc
e
protein
serocomplex
exhibit
vari
degre
antigen
similar
phylogenet
structur
across
highli
ecolog
divers
flavivirus
base
entir
code
region
reflect
antigen
group
well
host
andor
vector
associ
three
main
clade
emerg
flavivirus
recogn
ictv
mbfv
tickborn
flavivirus
tbfv
restrict
vertebr
host
known
vector
nkv
diverg
taxon
repres
phylogeni
flavivirus
anoth
candid
flaviviru
tamana
bat
viru
flavivirus
zoonot
transmit
human
anim
via
vector
tick
mosquito
suggest
retain
evolutionari
capac
hostswitch
spite
phylogenet
pattern
mackenzi
william
genom
observ
differ
flavivir
group
support
hostandor
vectorspecif
adapt
within
tbfv
virus
cluster
accord
antigen
group
host
associ
tightli
correl
associ
close
tbfv
mbfv
lineag
flavivirus
restrict
vertebr
nkv
within
mbfv
virus
phylogenet
subdivid
larg
keep
antigen
group
within
dengu
serocomplex
current
describ
serotyp
e
protein
consist
conserv
variabl
region
amino
acid
diverg
heinz
stiasni
presenc
conserv
region
account
brief
order
month
crossprotect
serotyp
sabin
diminish
andor
weakli
neutral
crossreact
antibodi
contribut
sever
diseas
dengu
antibodydepend
enhanc
ade
infect
bashyam
et
al
halstead
simasthien
madi
et
al
end
degre
variabl
e
protein
result
serolog
distinct
among
dengu
serotyp
mean
crossprotect
second
third
fourth
infect
although
clinic
ill
mild
third
fourth
infect
halstead
et
al
b
c
halstead
palumbo
e
protein
primari
target
neutral
antibodi
format
due
critic
role
host
cell
endocytosi
fusion
epitop
map
three
e
protein
domain
ii
iii
domain
ii
near
fusion
loop
later
ridg
domain
iii
import
neutral
target
ansarahsobrinho
et
al
de
alwi
et
al
wahala
silva
recent
year
great
deal
research
denv
biolog
provid
enorm
amount
inform
molecular
aspect
replic
studi
molecular
virolog
virus
made
possibl
use
fulllength
complementari
dna
cdna
clone
genom
rna
report
gene
replicon
fulllength
cdna
clone
four
serotyp
dengu
construct
use
studi
molecular
biolog
kapoor
et
al
kinney
et
al
lai
et
al
suzuki
et
al
infecti
clone
use
genet
manipul
differ
region
viral
rna
defin
function
viral
protein
rna
structur
studi
interact
gener
liveattenu
vaccin
candid
anoth
import
advanc
develop
genom
subgenom
denv
rna
contain
report
gene
luciferas
green
fluoresc
protein
gfp
schoggin
et
al
zou
et
al
tool
use
studi
function
viral
protein
rna
step
viral
life
cycl
samsa
et
al
also
reportercontain
virus
employ
studi
viral
function
interact
viral
entri
viral
translat
rna
synthesi
format
infecti
viral
particl
replicon
yet
anoth
use
tool
evalu
translat
viral
rna
amplif
follow
measur
report
activ
function
time
rna
transfect
matur
denv
particl
diamet
electrondens
core
surround
lipid
bilay
two
transmembran
viral
protein
insert
form
glycoprotein
shell
core
contain
nucleocapsid
form
viral
rna
genom
complex
multipl
copi
capsid
protein
glycoprotein
shell
well
defin
consist
copi
envelop
e
membran
protein
prmm
e
protein
found
headtotail
homodim
lie
flat
viral
surfac
form
smooth
protein
shell
kuhn
et
al
protein
small
proteolyt
fragment
precursor
prm
cleavag
pr
peptid
viral
matur
remain
transmembran
protein
beneath
e
protein
shell
insid
lipid
bilay
lowdens
gap
follow
densiti
contribut
capsid
protein
viral
genom
viral
particl
initi
assembl
immatur
viru
distinct
structur
organ
immatur
viral
particl
e
glycoprotein
associ
glycoprotein
prm
form
heterodim
zhang
et
al
immatur
particl
convert
infecti
form
cleavag
releas
pr
peptid
prm
protein
viral
denv
enter
host
cell
receptormedi
endocytosi
involv
bind
e
cellular
receptor
denv
must
recogn
ubiquit
cell
surfac
molecul
util
multipl
receptor
cell
entri
interact
e
glycosaminoglycan
heparan
sulfat
cell
surfac
also
sever
surfac
protein
implic
process
intern
heatshock
protein
bip
jindadamrongwech
et
al
neolactotetraosylceramid
aoki
et
al
lipopolysaccharid
receptor
chen
et
al
kda
highaffin
laminin
ctype
lectin
dendrit
cell
dc
specif
intercellular
adhes
nonintegrin
sign
mannos
receptor
miller
et
al
ctype
lectin
domain
famili
member
chen
et
al
denv
enter
mosquito
human
cell
clathrinmedi
endocytosi
krishnan
et
al
denv
particl
diffus
along
cell
surfac
toward
preexist
clathrinco
pit
aid
dynamin
clathrinco
pit
evolv
clathrinco
vesicl
viruscontain
vesicl
deliv
earli
endosom
subsequ
matur
late
endosom
upon
intern
acidif
endosom
fusion
viral
vesicular
membran
mediat
conform
chang
e
protein
modi
et
al
nayak
et
al
allow
releas
nucleocapsid
nucleocapsid
deliv
cytoplasm
uncoat
genom
involv
dissoci
capsid
protein
rna
take
place
unknown
process
positivesens
viral
rna
releas
cytoplasm
function
mrna
translat
singl
orf
rer
produc
larg
polyprotein
display
complex
topolog
er
membran
viral
polyprotein
cleav
coand
posttransl
least
matur
protein
nterminu
polyprotein
encod
three
structur
protein
capsid
prm
e
rest
orf
encod
seven
ns
protein
polyprotein
matur
carri
host
viral
proteas
host
signal
peptidas
er
lumen
respons
nterminu
cleavag
prm
e
wherea
process
ns
protein
well
cterminu
capsid
protein
carri
viral
proteas
cytoplasm
infect
cell
falgout
et
al
final
furin
proteas
respons
process
prm
golgi
apparatu
viral
particl
matur
viral
protein
translat
process
virusinduc
hypertrophi
intracellular
membran
occur
creat
structur
known
convolut
membran
cm
vesicl
packet
vp
rna
synthesi
take
place
close
associ
cellular
membran
insid
vp
socal
viral
replic
complex
rc
process
replic
begin
synthesi
complementari
negativestrand
rna
serv
templat
amplif
addit
positivestrand
genom
rna
enzymat
reaction
catalyz
associ
viral
ns
protein
presum
host
factor
newli
synthes
genom
use
translat
viral
protein
associ
capsid
gener
new
viral
particl
capsid
distribut
er
membran
nucleu
surfac
lipid
droplet
samsa
et
al
form
nucleocapsid
bud
er
lumen
acquir
lipid
bilay
togeth
viral
e
prm
protein
newli
produc
particl
travel
secretori
pathway
furinmedi
proteolysi
prm
transgolgi
network
trigger
rearrang
homodimer
e
format
matur
viral
particl
secret
virus
mixtur
matur
immatur
partial
matur
particl
denv
genom
consist
singl
positivestrand
rna
kb
type
cap
present
end
follow
conserv
dinucleotid
cleav
dubin
end
genom
lack
polyadenyl
tail
termin
conserv
cuoh
wengler
wengler
genom
encod
singl
orf
flank
highli
structur
untransl
region
utr
termin
rna
sequenc
genom
form
larg
stem
loop
structur
known
stem
loop
sla
stem
loop
sl
respect
essenti
viral
replic
utr
sequenc
four
denv
serotyp
nucleotid
long
utr
rang
nucleotid
case
nucleotid
import
featur
denv
flaviviru
genom
presenc
invert
complementari
sequenc
css
end
rna
sequenc
mediat
longrang
interact
cycliz
viral
genom
villordo
gamarnik
fig
invert
css
suggest
allow
end
genom
associ
base
pair
lead
circular
conform
rna
cs
element
found
within
code
sequenc
capsid
cs
cs
identifi
within
utr
upstream
conserv
sl
addit
invert
complementari
nucleotid
besid
origin
cs
notic
use
fold
predict
algorithm
leyssen
et
al
thurner
et
al
sequenc
locat
upstream
translat
initi
aug
utr
denv
found
complementari
region
present
within
stem
sl
pair
css
name
cycliz
sequenc
uar
name
stand
upstream
aug
region
alvarez
et
al
recent
complementari
nucleotid
locat
uar
cs
found
also
import
effici
denv
replic
sequenc
name
downstream
aug
region
frieb
et
al
atom
forc
microscopi
show
longrang
interact
occur
denv
genom
alvarez
et
al
also
show
fulllength
denv
genom
rna
occur
linear
circular
conform
align
utr
differ
denv
serotyp
show
high
sequenc
conserv
rnafold
predict
sequenc
indic
format
larg
termin
sla
follow
smaller
stem
loop
structur
stem
loop
b
slb
slb
end
translat
initi
aug
codon
contain
cs
uar
two
stem
loop
structur
separ
short
oligo
u
sequenc
sla
portion
denv
genom
show
three
helic
region
side
stem
loop
ssl
top
loop
tl
structur
play
import
role
viral
replic
sla
slb
structur
oligo
u
track
conserv
denv
flaviviru
genom
function
spacer
enhanc
viral
rna
synthesi
lodeiro
et
al
utr
follow
structur
rna
region
code
sequenc
capsid
region
nucleotid
long
contain
three
import
rna
element
highli
conserv
cs
complementari
cs
present
viral
utr
stabl
hairpin
known
capsid
region
hairpin
chp
rna
element
modul
denv
replic
mosquito
mammalian
cell
fig
cs
nucleotid
long
absolut
conserv
among
four
denv
serotyp
region
mediat
longrang
interact
end
genom
essenti
viral
rna
replic
chp
origin
describ
element
regul
start
codon
select
protein
synthesi
rna
structur
locat
within
protein
code
sequenc
found
play
regulatori
role
denv
replic
polacek
et
al
mutat
delet
within
predict
hairpin
result
import
defect
denv
replic
mosquito
mammalian
cell
fig
utr
four
denv
genom
contain
highli
conserv
rna
element
shurtleff
et
al
howev
length
region
differ
four
serotyp
case
utr
nucleotid
long
nucleotid
nucleotid
shortest
nucleotid
utr
divid
three
domain
proutski
et
al
rauscher
et
al
domain
locat
immedi
stop
codon
consid
variabl
region
within
viral
utr
domain
ii
moder
conserv
compris
sever
hairpin
motif
includ
characterist
dumbbel
structur
turret
structur
propos
shurtleff
et
al
silva
et
al
domain
iii
conserv
region
utr
bear
conserv
sequenc
follow
termin
stem
loop
structur
sl
contain
cycliz
sequenc
cs
involv
longrang
interact
hahn
et
al
serotyp
nucleotid
variat
region
alter
shp
format
impair
denv
replic
villordo
et
al
tl
larg
termin
stem
loop
denv
highli
conserv
acagaac
sequenc
denv
sl
contain
total
nucleotid
long
stem
interrupt
mismatch
conserv
locat
sixnucleotid
bulg
predict
near
top
loop
contain
seven
nucleotid
serotyp
nucleotid
variat
region
specif
nucleotid
sl
interact
rna
element
viral
genom
provid
correct
conform
initi
rna
synthesi
also
possibl
sl
provid
recognit
site
protein
bind
assembl
rna
rc
fig
end
flaviviru
rna
genom
contain
complementari
ribonucleotid
sequenc
lead
cycliz
genom
fig
replic
denv
associ
dramat
rearrang
host
cellular
membran
mackenzi
et
al
uchil
satchidanandam
welsch
et
al
least
three
differ
membran
structur
describ
flavivirusinfect
cell
structur
origin
describ
cm
paracrystallin
array
vp
current
studi
support
er
origin
vp
cm
induc
denv
infect
cm
propos
put
site
flaviviru
polyprotein
process
role
cm
storag
site
protein
lipid
involv
viral
replic
propos
intermedi
form
rna
replic
ns
viral
protein
observ
insid
vp
electron
microscopi
em
confirm
biochem
analysi
mackenzi
et
al
welsch
et
al
westaway
et
al
viral
rna
replic
begin
synthesi
negativestrand
rna
serv
templat
synthesi
addit
posit
strand
process
occur
close
associ
cellular
membran
like
vp
socal
viral
rc
enzymat
reaction
catalyz
rdrp
activ
togeth
viral
ns
protein
presum
host
factor
rna
synthesi
semiconserv
asymmetr
lead
excess
posit
neg
strand
cleav
dubin
three
speci
viral
rna
metabol
label
ribonucleaseresist
doublestrand
rna
dsrna
call
replic
form
form
partial
resist
ribonucleas
like
compos
rna
complementari
nascent
elong
strand
known
replic
intermedi
genom
rna
fulli
sensit
ribonucleas
studi
show
viral
protein
virus
coloc
dsrna
mackenzi
et
al
welsch
et
al
westaway
et
al
rna
synthesi
occur
within
lumen
vesicl
newli
synthes
rna
genom
exit
via
identifi
pore
commun
cytosol
two
viral
protein
bear
enzymat
activ
directli
involv
rna
replic
protein
interact
differ
viral
host
compon
display
multipl
function
viral
infect
also
part
rc
involv
viral
rna
amplif
mackenzi
et
al
westaway
et
al
upon
entri
viral
genom
directli
use
messeng
protein
synthesi
associ
rer
matur
viral
protein
reorgan
cellular
membran
gener
structur
known
vp
contain
rc
suffici
viral
protein
synthes
translat
stop
rna
transport
vp
unknown
mechan
possibl
accumul
viral
protein
host
factor
induc
protein
coordin
switch
translat
rna
synthesi
insid
vp
viral
protein
like
bind
intern
side
membran
stay
outer
side
correspond
er
lumen
viral
polymeras
must
transport
insid
vp
presum
bound
viral
rna
rna
transport
could
mediat
ns
protein
possibl
host
factor
rna
synthesi
specif
interact
sla
promot
end
genom
base
pair
end
rna
cycliz
genom
allow
reloc
end
molecul
initi
rna
synthesi
hybrid
css
uar
open
bottom
half
highli
structur
sl
allow
initi
negativestrand
synthesi
synthes
dinucleotid
cu
de
novo
serv
primer
rna
elong
propos
negativestrand
rna
remain
bound
posit
strand
dsrna
form
neg
strand
serv
templat
positivestrand
amplif
multipl
copi
positivestrand
rna
made
neg
strand
lead
excess
posit
versu
neg
strand
newli
made
genom
exit
vp
pore
connect
cytoplasm
molecul
either
associ
reorgan
er
presum
cm
structur
mediat
new
round
translat
viral
protein
associ
capsid
protein
form
nucleocapsid
nucleocapsid
bud
er
gener
new
viral
particl
fig
kda
glycoprotein
muller
et
al
found
interact
virusinduc
vesicl
insid
cell
secret
cell
surfac
releas
bloodstream
infect
individu
flamand
et
al
winkler
et
al
thought
play
import
role
viru
replic
shown
coloc
viral
rna
rc
secret
highli
immunogen
involv
stimul
protect
respons
denv
mackenzi
et
al
implic
earli
stage
flaviviru
rna
synthesi
lindenbach
rice
protein
exist
multipl
oligomer
form
found
differ
cellular
locat
associ
vesicular
compart
found
cell
surfac
secret
coloc
rc
togeth
dsrna
vp
mackenzi
et
al
westaway
et
al
exist
differ
oligomer
state
associ
membran
virusinduc
vesicl
cell
plasma
membran
exist
dimer
form
secret
cell
becom
hexam
gutsch
et
al
structur
nm
diamet
nm
height
exist
barrellik
structur
dimer
arrang
trimer
contain
triglycerid
cholesterol
charg
lipid
phosphatidylcholin
phosphatidylethanolamin
muller
et
al
kda
small
hydrophob
integr
membran
protein
implic
viral
rna
synthesi
viral
particl
assembl
xie
et
al
essenti
compon
replicas
also
inhibitor
interferon
ifn
product
two
form
protein
observ
result
intern
cleavag
viral
proteas
suggest
physic
interact
interact
rna
transcript
utr
also
suggest
lindenbach
et
al
protein
residu
produc
posttransl
cleavag
proteas
termin
end
predict
compris
three
hydrophob
region
span
membran
addit
short
highli
conserv
hydrophil
stretch
residu
amino
acid
involv
catalyt
activ
proteas
act
cofactor
darci
et
al
essenti
viral
polyprotein
process
anglerorodriguez
et
al
protein
kda
variou
enzymat
activ
essenti
replic
viral
genom
rna
viral
polyprotein
proteolyt
process
via
serin
proteas
ntermin
domain
rna
helicas
nucleosid
triphosphatas
ntpase
rna
nucleosid
triphosphatas
rtpase
via
ctermin
domain
catalyt
activ
ntermin
domain
must
associ
hydrophil
domain
membraneassoci
protein
act
cofactor
repres
import
target
develop
specif
antivir
inhibitor
patkar
kuhn
reiser
et
al
bear
multipl
essenti
enzymat
activ
besid
ntermin
twocompon
serin
proteas
domain
necessari
polyprotein
process
contain
three
differ
enzymat
activ
ctermin
domain
ntpase
rna
triphosphatas
rtpase
rna
helicas
benarroch
et
al
yon
et
al
possibl
function
includ
unwind
dsrna
intermedi
aris
rna
amplif
destabil
secondari
structur
rna
increas
polymeras
process
particip
rna
recruit
specif
subcellular
locat
act
rnpase
strip
protein
viral
rna
remodel
rna
structur
may
function
modul
viral
process
found
induc
dissoci
ssrna
promot
dsrna
unwind
activ
umareddi
et
al
implic
infecti
viral
particl
format
patkar
kuhn
small
transmembran
hydrophob
protein
one
least
character
protein
rc
involv
format
vp
cm
miller
et
al
contain
sever
hydrophob
region
coloc
dsrna
denvinfect
cell
miller
et
al
topolog
model
propos
ntermin
region
local
cytoplasm
remain
contain
three
transmiss
electron
microscopi
tm
segment
miller
et
al
hydrophob
protein
kda
partial
block
activ
ifnstimul
gene
isg
cell
stimul
ifn
viral
enzym
respons
rna
cap
rna
synthesi
posit
neg
rna
strand
issur
et
al
yap
et
al
largest
conserv
viral
protein
contain
ntermin
sadenosylmethioninedepend
mtase
involv
rna
cap
format
ctermin
rdrp
domain
rdrp
requir
viral
rna
synthesi
bartholomeusz
et
al
egloff
et
al
specif
copi
viral
rna
specif
depend
viral
rna
structur
act
promot
present
end
viral
genom
known
sla
lodeiro
et
al
ntermin
denv
shown
possess
guanin
ribos
mtase
activ
involv
format
cap
egloff
et
al
also
block
type
ifn
bind
promot
degrad
ashour
et
al
denv
rna
synthesi
requir
specif
interact
sla
structur
present
end
viral
genom
end
rna
necessari
polymeras
activ
also
termin
transferas
activ
interfer
vitro
studi
analyz
abil
protein
copi
rna
templat
specif
rna
synthesi
provid
viral
sequenc
present
end
genom
utr
element
necessari
promot
rna
synthesi
vitro
denv
bind
promot
sla
mainli
rdrp
domain
iglesia
et
al
crystallograph
structur
rdrp
domain
wnv
denv
serotyp
yap
et
al
show
right
structur
compos
finger
palm
thumb
subdomain
unexpect
observ
structur
rdrp
denv
presenc
two
zinc
ion
thumb
finger
subdomain
respect
capsid
kda
highli
charg
basic
protein
detect
cytoplasm
nucleu
sangiambut
et
al
primari
role
capsid
cytoplasm
assembl
viru
particl
interact
viral
rna
genom
er
membran
markoff
et
al
known
interact
nuclear
protein
eg
histon
nucleolar
rna
helicas
importinab
bhuvanakantham
et
al
netsawang
et
al
xu
et
al
abl
caus
apoptosi
capsid
protein
consist
disord
ntermin
end
follow
four
helic
disord
ntermin
end
highli
posit
charg
follow
hydrophob
helic
amphipath
highli
charg
ntermin
end
could
import
rna
bind
westaway
et
al
helic
interact
lipid
membran
markoff
et
al
e
protein
major
antigen
structur
denv
involv
host
cell
receptor
recognit
fusion
viru
endosom
membran
cell
entri
rey
et
al
e
protein
thought
exist
dimer
expos
low
ph
mimic
condit
endosom
e
protein
rearrang
form
trimer
bressanelli
et
al
modi
et
al
e
protein
elong
protein
mainli
compos
organ
three
domain
central
domain
dimer
domain
ii
igclik
domain
iii
dimer
assembl
two
monom
arrang
headtotail
format
tip
domain
ii
contain
fusion
loop
interact
endosom
membran
fusion
event
modi
et
al
mechan
fusion
e
protein
lead
intern
denv
propos
modi
et
al
involv
domain
ii
domain
iii
follow
manner
low
ph
environ
endosom
domain
ii
e
protein
flip
expos
fusion
loop
therebi
lead
insert
fusion
loop
endosom
membran
membran
may
catalyz
trimer
caus
format
prefus
intermedi
trimer
spread
fusion
tip
e
protein
downward
domain
base
trimer
domain
iii
rotat
shift
displac
trimer
turn
caus
endosom
viral
membran
fuse
fusion
membran
may
requir
concert
twist
trimer
e
protein
prm
protein
present
newli
synthes
immatur
viru
surfac
furin
proteasecleav
deriv
protein
present
matur
infecti
viru
prm
protein
consist
ntermin
pr
molecul
follow
ectodomain
tm
region
primari
role
pr
molecul
cap
fusion
loop
e
protein
thu
prevent
newli
synthes
viru
fuse
back
cell
move
acid
compart
transgolgi
network
hand
function
protein
remain
larg
unknown
pr
peptid
consist
mainli
antiparallel
strand
cap
fusion
loop
e
protein
consist
propos
function
prevent
viru
fuse
back
cell
exocytosi
fig
viral
virul
influenc
viral
genet
intrins
viru
host
factor
preexist
immun
host
genet
factor
extrins
viru
certain
denv
strain
demonstr
greater
epidem
potenti
replic
better
either
human
mosquito
vector
therefor
potenti
displac
strain
lower
rel
replic
abil
either
host
enhanc
replic
mosquito
may
contribut
global
spread
success
strain
due
faster
dissemin
mosquito
shorter
extrins
incub
period
anderson
ricohess
gubler
rosen
also
crossreact
immun
respons
human
popul
may
also
confer
select
advantag
particular
clade
genotyp
denv
strain
capabl
evad
host
adapt
immun
respons
abl
outcompet
strain
popul
ohainl
et
al
vu
et
al
halstead
propos
denv
share
common
immunodomin
epitop
due
amino
acid
ident
may
four
serotyp
term
sequenti
infect
halstead
genet
chang
certain
viral
strain
confer
greater
virul
compar
other
probabl
reason
variat
sever
dengu
epidem
per
thenpropos
altern
hypothesi
call
viru
virul
hypothesi
rosen
support
sever
studi
denv
virul
often
tightli
link
host
immun
statu
particularli
difficult
separ
role
viral
versu
host
factor
includ
host
genet
ohainl
et
al
steel
et
al
fit
denv
strain
propos
pose
increas
risk
caus
sever
diseas
less
fit
strain
due
propens
higher
replic
human
host
ricohess
viremia
level
patient
associ
diseas
sever
sever
studi
librati
et
al
tricou
et
al
three
mechan
increas
viral
replic
propos
would
allow
higher
viral
replic
human
host
lead
higher
pathogen
robust
infect
target
cell
result
exacerb
cytokin
cascad
pathogen
denv
strain
replic
product
human
cell
therebi
replic
higher
titer
cologna
ricohess
pathogen
denv
strain
may
evad
host
adapt
crossreact
immun
respons
kochel
et
al
mongkolsapaya
et
al
antibodymedi
infect
may
increas
viral
replic
infect
target
cell
balsiti
et
al
boonnak
et
al
zellweg
et
al
increas
viral
output
infect
cell
also
inappropri
crossreact
adapt
immun
respons
sequenti
denv
infect
may
lead
sever
immunopathogenesi
characterist
dhfdss
chang
viral
protein
interact
host
may
impact
viral
virul
interact
includ
interact
host
complement
pathway
potenti
immun
recognit
bound
endotheli
cell
vascular
system
avirutnan
et
al
chen
et
al
cleavag
matur
appear
induc
immunomedi
monocyt
increas
endotheli
cell
permeabl
kelley
et
al
final
differ
breadth
divers
circul
denv
genom
acut
infect
intrahost
divers
hypothes
play
role
determin
diseas
outcom
descloux
et
al
halstead
et
al
demonstr
isol
case
sever
dengu
diseas
grew
better
human
monocyt
cell
isol
mild
symptomat
ill
also
increas
virul
asian
human
infect
link
enhanc
replic
vitro
mutat
certain
posit
might
increas
decreas
virul
base
site
mutagenesi
addit
mutat
may
alter
replic
abil
denv
virus
human
cell
virus
may
also
less
sensit
elimin
host
immun
system
includ
reduc
neutral
host
humor
antibodymedi
respons
four
denv
serotyp
abil
caus
sever
fatal
diseas
human
although
often
associ
sever
diseas
serotyp
less
symptomat
primari
infect
other
often
symptomat
even
lead
sever
diseas
primari
infect
balmaseda
et
al
fri
et
al
nisalak
et
al
addit
viral
strain
within
serotyp
may
differ
one
anoth
abil
infect
caus
symptomat
diseas
either
denvimmun
individu
primari
secondari
infect
specif
sequenc
infect
heterolog
serotyp
may
import
determin
diseas
outcom
ohainl
et
al
interepidem
period
denv
thought
maintain
endem
popul
silent
transmiss
time
viru
may
undergo
signific
evolut
also
seen
denv
evolv
singl
epidem
season
virus
isol
end
epidem
differ
virus
isol
earlier
mechan
chang
unclear
ohainl
et
al
age
risk
factor
develop
sever
diseas
death
denv
infect
mani
studi
indic
incid
dss
highest
children
age
year
younger
children
significantli
higher
chanc
die
infect
ander
et
al
may
due
reason
younger
children
intrins
permeabl
vascular
endothelium
therefor
prone
signific
plasma
leak
gambl
et
al
host
genet
play
vital
role
suscept
denv
infect
studi
show
peopl
african
ancestri
reduc
risk
develop
sever
diseas
compar
european
ancestri
recent
genomewid
associ
studi
gwa
help
establish
link
host
genet
diseas
suscept
highli
polymorph
human
leukocyt
antigen
hla
allel
propos
associ
either
diseas
suscept
protect
coffey
et
al
hlaa
associ
less
sever
diseas
irrespect
infect
serotyp
wherea
hlaa
associ
sever
diseas
patient
secondari
contrast
hlaa
associ
sever
diseas
irrespect
serotyp
hlaa
associ
less
sever
diseas
phenotyp
secondari
infect
addit
variou
hlab
allel
appear
protect
develop
clinic
diseas
secondari
denv
infect
stephen
et
al
also
hlaa
overrepres
patient
sever
diseas
wherea
underrepres
suggest
associ
suscept
protect
respect
nguyen
et
al
sever
gene
polymorph
also
associ
denv
infect
tumor
necrosi
factor
tnf
allel
increas
suscept
sever
manifest
denv
infect
perez
et
al
possibl
protect
associ
allel
sever
denv
infect
garcia
et
al
increas
frequenc
transform
growth
factor
beta
cc
genotyp
case
dhf
compar
milder
df
cheng
et
al
genotyp
singl
nucleotid
polymorph
snp
posit
vdr
gene
associ
protect
sever
dengu
loke
et
al
also
show
homozygot
arginin
variant
posit
receptor
ii
gene
appear
protect
develop
sever
denv
infect
viral
bind
platelet
via
human
platelet
antigen
may
result
thrombocytopenia
observ
sever
infect
g
allel
appear
protect
milder
denv
infect
df
seriou
diseas
sakuntabhai
et
al
gwa
demonstr
suscept
loci
sever
dengu
major
histocompat
mhc
class
mhc
polypeptiderel
sequenc
b
micb
chromosom
phospholipas
c
epsilon
chromosom
khor
et
al
micb
gene
associ
natur
killer
nk
cell
activ
highli
express
acut
dengu
infect
host
immun
respons
consid
contribut
mani
clinic
complic
associ
sever
dengu
capillari
permeabl
develop
time
viral
burden
sharp
declin
argu
direct
viru
mediat
effect
vascular
endothelium
sever
complic
capillari
permeabl
dss
manifest
mani
patient
low
undetect
viremia
level
alreadi
nearli
afebril
simmon
et
al
second
line
evid
support
immun
pathogenesi
model
sever
dengu
lie
observ
vast
major
sever
dengu
complic
occur
patient
immunolog
evid
previou
histori
denv
exposur
case
infant
matern
acquir
antidenv
antibodi
product
proinflammatori
cytokin
immun
cell
cours
infect
key
mechanist
process
capillari
permeabl
vasodilatori
potenti
cytokin
occur
elev
concentr
acut
dengu
link
endotheli
cell
dysfunct
hypothesi
cytokin
storm
mediat
capillari
permeabl
support
ade
hypothesi
greater
viru
burden
concept
immun
activ
memori
crossreact
cell
secondari
infect
kinet
antibodi
product
dengu
follow
typic
cours
found
mani
viral
infect
initi
phase
igm
product
follow
igg
primari
denv
infect
antidengu
igm
level
begin
rise
day
follow
onset
fever
detect
almost
case
follow
defervesc
next
month
igm
level
fall
replac
igg
detect
lifelong
propos
provid
protect
repeat
infect
serotyp
reinfect
differ
serotyp
halstead
inni
et
al
kuran
sabin
summer
et
al
follow
secondari
infect
rise
igm
much
less
mark
follow
primari
infect
absent
instead
igg
level
rise
rapidli
higher
peak
differ
form
basi
test
distinguish
primari
secondari
dengu
infect
primari
infect
infer
igm
igg
ratio
convers
secondari
infect
infer
ratio
ade
propos
halstead
orourk
explain
increas
sever
seen
secondari
dengu
infect
propos
due
larg
sequenc
divers
denv
antibodi
made
primari
infect
viru
suffici
avid
titer
neutral
secondari
infect
viru
instead
low
avid
crossreact
antibodi
may
opson
viru
lead
target
fcr
bear
cell
macrophagemonocyt
lead
intern
increas
viru
replic
fcria
fcriia
shown
promot
ade
cytoplasm
domain
contain
immunotyrosin
activ
motif
essenti
function
promot
endocytosi
immun
complex
halstead
orourk
b
ade
therefor
phenomenon
fail
neutral
densiti
antibodi
bind
insuffici
caus
neutral
larg
enough
pass
threshold
requir
direct
opson
virion
fc
intern
ade
demonstr
increas
viru
replic
primat
model
follow
passiv
transfer
polyclon
human
serum
monoclon
antibodi
mab
goncalvez
et
al
halstead
et
al
antiprm
antibodi
particularli
interest
group
antibodi
respect
ade
antiprm
antibodi
show
poor
neutral
typic
even
high
concentr
neutral
plateau
reason
like
viru
matur
fulli
matur
viru
particl
contain
prm
thu
neutral
wherea
mani
partial
matur
viru
particl
contain
enough
prm
bind
antibodi
drive
ade
enough
prm
epitop
allow
suffici
antibodi
densiti
neutral
furthermor
virion
high
level
prm
infecti
driven
infect
cell
ade
antiprm
antibodi
rodenhuiszybert
et
al
result
endocytosi
suffici
prm
process
allow
membran
fusion
number
way
antibodi
protect
viral
infect
simpl
term
antibodi
may
block
adhes
cellular
receptor
block
fusion
host
cell
membran
altern
destroy
viru
virusinfect
cell
via
complement
antibodydepend
cellmedi
cytotox
final
antibodi
may
opson
viru
direct
dispos
via
fc
uptak
antibodi
block
viral
entri
explain
number
theori
two
promin
singlehit
model
multiplehit
model
singlehit
model
propos
interact
antibodi
singl
small
number
critic
epitop
may
lock
viru
conform
prevent
infect
dulbecco
et
al
multiplehit
model
convers
propos
rather
critic
epitop
neutral
achiev
proport
virion
surfac
occlud
antibodi
thu
interf
viral
attach
andor
fusion
dellaporta
westaway
shown
reduc
viru
replic
vivo
propos
mediat
either
antibodiescompl
cellmedi
cytotox
amorim
et
al
costa
et
al
wu
et
al
immun
complex
activ
complement
propos
drive
complement
consumpt
promot
vascular
leak
final
antibodi
shown
crossreact
unknown
epitop
platelet
endothelium
propos
drive
dengu
pathogenesi
lin
et
al
abil
antibodi
neutral
viru
thu
relat
function
avid
whole
virion
cell
recogn
short
antigen
peptid
bound
peptid
bind
groov
mhc
mhc
class
ii
mhc
ii
molecul
peptid
bound
molecul
normal
short
fragment
deriv
degrad
normal
cellular
protein
howev
infect
acquir
present
peptid
replic
pathogen
gener
mhc
molecul
bind
peptid
deriv
protein
express
intracellularli
viru
replic
host
cell
present
cytotox
cell
mhc
ii
molecul
hand
present
peptid
deriv
endocytos
antigen
cell
peptid
predict
algorithm
abil
synthes
larg
number
peptid
help
us
understand
tcell
respons
denv
person
use
techniqu
larg
number
epitop
mhc
mhc
ii
map
seem
immunodomin
region
viru
mani
epitop
describ
human
duangchinda
et
al
kuran
et
al
mani
cell
induc
secondari
infect
show
poor
respons
secondari
infect
viru
cell
dhf
produc
cytokin
show
less
degranul
df
cell
show
much
higher
level
degranul
absenc
cytokin
product
duangchinda
et
al
mani
rais
peak
level
coincid
onset
sever
symptom
high
level
tnfa
ifng
mif
solubl
tnfri
solubl
tnfrii
rant
record
mani
product
activ
cell
dejnirattisai
et
al
dhf
may
result
immunopatholog
immunopatholog
increasingli
recogn
number
viral
diseas
protect
antivir
respons
although
capabl
control
viru
may
caus
consider
inflamm
tissu
damag
instanc
fatal
friberg
et
al
mongkolsapaya
et
al
denv
counteract
two
import
element
innat
immun
name
complement
type
ifn
pathway
counteract
mechan
allow
viru
establish
infect
human
possibl
affect
gener
effect
adapt
immun
respons
initi
regul
dc
moreov
element
involv
antivir
innat
immun
respons
target
denv
denv
shown
trigger
complement
activ
vitro
vivo
complement
like
function
limit
denv
infect
stimul
adapt
immun
respons
neutral
infect
engag
antibodi
vitro
vivo
paradox
enhanc
replic
denv
balsiti
et
al
zellweg
et
al
complement
also
augment
antibodymedi
neutral
flavivirus
includ
yfv
denv
wnv
mehlhop
et
al
myeloid
cell
express
complement
receptor
antibodydepend
complement
activ
paradox
may
enhanc
flaviviru
infect
cardosa
et
al
antibodi
complementdepend
opson
may
augment
denv
infect
myeloid
cell
earli
clinic
studi
reduc
level
factor
b
increas
catabol
rate
observ
particularli
patient
sever
denv
diseas
secondari
infect
bokisch
et
al
addit
split
product
anaphylatoxin
accumul
circul
ill
patient
peak
day
maximum
vascular
leakag
malasit
denvinfect
cell
may
display
suffici
amount
denv
antigen
prm
e
protein
surfac
facilit
immun
complex
format
complement
deposit
inde
denvinfect
endotheli
cell
activ
human
complement
presenc
antibodi
result
deposit
type
ifn
product
cascad
trigger
viru
infect
sensor
cascad
includ
tolllik
receptor
tlr
cytoplasm
receptor
retino
acidinduc
gene
rig
rig
receptor
rlr
detect
virusspecif
element
pamp
initi
cascad
ashour
et
al
activ
cascad
result
product
type
ifn
cell
subsequ
secret
antivir
cytokin
act
autocrin
paracrin
manner
bind
receptor
trigger
ifn
signal
cascad
culmin
activ
isgscontain
ifnstimul
respons
element
antivir
activ
kawai
akira
denv
report
sens
sever
tlr
rlr
includ
rig
nasirudeen
et
al
sever
denv
protein
identifi
inhibitor
type
ifn
signal
inhibit
detect
effector
arm
import
pathway
viru
stop
product
type
ifn
would
trigger
induct
hundr
isg
also
denv
inhibit
product
type
ifn
infect
primari
human
cell
monocyt
monocytederiv
dc
monocytederiv
macrophag
inhibit
mediat
activ
proteas
complex
target
key
host
factor
sting
also
name
mita
morrison
et
al
sting
adaptor
molecul
type
ifn
product
mediat
phosphoryl
transcript
factor
transloc
nucleu
particip
activ
promot
addit
direct
effect
viral
replic
inhibit
type
ifn
product
human
dc
denv
may
affect
qualiti
adapt
immun
respons
gener
infect
follow
infecti
mosquito
bite
incub
period
week
commonli
day
individu
develop
symptom
suddenli
ill
typic
follow
three
phasesan
initi
febril
phase
critic
phase
start
around
day
fever
onset
complic
may
develop
follow
spontan
recoveri
phase
patient
experi
sudden
onset
high
fever
c
accompani
nonspecif
constitut
symptom
includ
headach
gener
malais
nausea
vomit
myalgia
joint
pain
biswa
et
al
sirivichayakul
et
al
common
symptom
includ
alter
tast
sensat
colicki
abdomin
pain
constip
diarrhea
occasion
dysuria
cough
sore
throat
rhinorrhea
sometim
present
gregori
et
al
occasion
temperatur
may
rise
high
c
first
day
febril
convuls
may
occur
suscept
children
examin
phase
ill
facial
flush
conjunctiv
suffus
gener
truncal
erythema
may
note
faint
macular
maculopapular
rash
present
case
gener
mild
enlarg
lymph
node
common
liver
often
palpabl
soft
littl
tender
although
rare
markedli
enlarg
jaundic
unusu
splenomegali
occasion
observ
small
infant
mild
hemorrhag
manifest
skin
petechia
andor
bruis
venepunctur
site
sometim
note
mucos
bleed
nose
gum
gastrointestin
genitourinari
tract
sometim
occur
laboratori
find
includ
mildtomoder
thrombocytopenia
leukopenia
often
mild
elev
hepat
transaminas
biswa
et
al
kalayanarooj
et
al
critic
phase
onset
occur
around
day
ill
last
hour
number
system
problem
may
develop
phase
ill
fear
complic
unexplain
vasculopathi
wherebi
increas
vascular
permeabl
result
capillari
leakag
syndrom
profound
plasma
loss
lead
potenti
fatal
hypovolem
shock
occur
small
proport
case
alter
capillari
permeabl
often
accompani
hemorrhag
manifest
hematolog
abnorm
specif
event
defin
time
onset
phase
vascular
leakag
often
becom
appar
around
day
ill
shock
occur
typic
develop
within
hour
defervesc
major
increas
vascular
permeabl
result
sever
plasma
leakag
typic
result
cardiovascular
collaps
within
hour
pleural
effus
ascit
overt
sign
cardiovascular
decompens
becom
appar
end
dss
estim
develop
case
trung
et
al
ultrasound
studi
indic
pleural
effus
ascit
gall
bladder
wall
edema
commonli
present
critic
phase
correl
diseas
sever
hypoproteinemia
well
recogn
critic
phase
correl
sever
leakag
will
et
al
howev
clinic
identif
increas
permeabl
difficult
unless
dss
develop
common
method
monitor
leakag
reli
identif
rel
hemoconcentr
unfortun
method
rather
insensit
particularli
patient
receiv
parenter
fluid
therapi
suffer
seriou
limit
individu
baselin
valu
rare
known
final
assess
hemoconcentr
may
possibl
acut
ill
resolv
narrow
puls
pressur
indic
plasma
volum
deplet
reach
critic
point
impli
decompens
shock
soon
follow
fluid
resuscit
institut
promptli
soon
puls
pressur
narrow
ongo
deplet
plasma
rapidli
becom
critic
systol
pressur
fall
irrevers
shock
death
may
follow
despit
aggress
resuscit
profound
prolong
shock
often
complic
tissu
hypoxia
metabol
acidosi
dissemin
intravascular
coagul
dic
also
liver
failur
renal
failur
encephalopathi
seen
associ
profound
shock
bleed
gastrointestin
tract
typic
seen
patient
profound
prolong
shock
complic
metabol
acidosi
andor
dic
minor
epistaxi
gum
bleed
gastrointestin
bleed
sometim
observ
children
without
shock
carlo
et
al
bleed
mucos
surfac
tend
common
sever
adult
intracrani
hemorrhag
rare
often
fatal
complic
wani
et
al
degre
thrombocytopenia
leukopenia
derang
hemostasi
virtual
univers
critic
phase
biswa
et
al
trung
et
al
moderatetosever
thrombocytopenia
common
typic
evolut
thrombocytopenia
consist
earli
marrow
suppress
megakaryocytopoiesi
follow
increas
peripher
destruct
platelet
late
febril
earli
convalesc
phase
diseas
probabl
mediat
evolv
immun
respons
infect
febril
phase
also
reduct
number
total
leukocyt
neutrophil
togeth
rel
increas
lymphocyt
number
often
includ
high
proport
atyp
lymphocyt
khan
et
al
increas
vascular
permeabl
abnorm
hemostasi
transient
usual
resolv
within
hour
howev
convalesc
may
prolong
adult
sometim
experi
profound
tired
esthenia
depress
sever
week
recoveri
seet
et
al
loss
hair
also
report
convalesc
dysfunct
specif
organ
eg
hepat
failur
myocard
may
persist
sever
week
resolut
vasculopathi
qiu
et
al
children
elderli
lower
threshold
leakag
adult
gambl
et
al
primari
infect
children
often
asymptomat
may
caus
rel
benign
nonspecif
febril
ill
endi
et
al
studi
shown
children
greater
risk
vascular
leakag
develop
dss
compar
adult
ander
et
al
trung
et
al
dengu
associ
mortal
also
appear
higher
pregnant
nonpregn
women
dengu
adam
et
al
respect
fetal
outcom
infect
known
associ
fetal
malform
tsai
et
al
comorb
bronchial
asthma
sickl
cell
anemia
diabet
mellitu
could
risk
factor
develop
sever
diseas
form
gonzalez
et
al
diabet
mellitu
hypertens
associ
sever
diseas
pang
et
al
also
diabet
mellitu
asthma
hypertens
ischem
heart
diseas
chronic
kidney
diseas
present
major
die
leo
et
al
promin
flush
skin
especi
face
neck
chest
may
seen
around
dengu
patient
blanch
macular
maculopapular
rash
describ
patient
first
develop
day
ill
trung
et
al
mild
nonspecif
symptom
sever
complic
result
perman
visual
loss
conjunctiv
inject
subconjunctiv
hemorrhag
retin
hemorrhag
retin
edema
macular
ischemia
macular
edema
vitreou
hemorrhag
vitriti
optic
neuriti
papil
report
infrequ
siqueira
et
al
musculoskelet
symptom
promin
featur
dengu
particularli
among
adult
patient
almost
adult
experi
degre
myalgia
associ
arthralgia
around
onethird
patient
featur
help
distinguish
dengu
febril
ill
creatin
kinas
level
sometim
said
markedli
elev
lactat
dehydrogenas
andor
aspart
aminotransferas
level
found
higher
dengueinfect
subject
wang
et
al
anorexia
nausea
vomit
diarrhea
abdomin
pain
report
commonli
nausea
vomit
anorexia
usual
found
first
day
ill
abdomin
pain
tend
develop
slightli
later
day
ill
persist
vomit
increasingli
sever
abdomin
pain
tender
consid
warn
sign
like
progress
sever
diseas
liver
dysfunct
describ
term
increas
hepat
transaminas
level
common
sirivichayakul
et
al
potenti
mechan
hepat
injuri
involv
varieti
possibl
insult
includ
direct
effect
viru
host
immun
respons
liver
cell
circulatori
compromis
andor
hypoxia
due
hypotens
local
vascular
leakag
insid
liver
capsul
hepatotox
effect
drug
acetaminophen
tradit
herbal
remedi
tissu
tropism
particular
viral
serotyp
genotyp
microscop
hematuria
found
around
dengu
patient
acut
ill
acut
renal
failur
rare
complic
usual
found
associ
sever
dss
typic
patient
prolong
shock
multiorgan
involv
common
cardiac
manifest
dengu
arrhythmia
sever
case
report
also
describ
disturb
sinoatri
block
atrioventricular
dissoci
atrial
fibril
critic
phase
kaushik
et
al
mahmod
et
al
convalesc
rhythm
disturb
sinu
paus
firstdegre
heart
block
mobitz
type
atrioventricular
block
describ
well
atrial
ventricular
ectopi
diagnosi
import
clinic
care
surveil
support
pathogenesi
studi
vaccin
drug
develop
clinic
trial
guzman
kouri
direct
viru
isol
rna
antigen
detect
indirect
method
serolog
investig
constitut
dengu
diagnost
tool
hunsperg
et
al
peel
et
al
diagnost
marker
studi
dengu
infect
depend
time
infect
immun
respons
method
techniqu
use
earli
stage
ill
viru
isol
antigen
nucleic
acid
detect
use
diagnos
infect
serolog
method
choic
diagnosi
end
acut
phase
ill
individu
bitten
infect
mosquito
incub
period
day
ensu
viremia
observ
day
fever
onset
day
onset
virem
period
viru
isol
rna
protein
detect
depend
number
infect
individu
develop
primari
secondari
tertiari
quaternari
respons
infect
antidengu
igm
antibodi
detect
case
day
onset
fever
usual
day
sometim
month
kuno
et
al
primari
infect
igg
antibodi
begin
appear
day
igm
antibodi
usual
day
fever
antibodi
titer
continu
rise
slowli
period
week
remain
detect
probabl
lifetim
secondari
infect
igg
antibodi
rapidli
rise
almost
immedi
fever
onset
high
level
patient
igm
antibodi
well
high
titer
igg
singl
serum
use
marker
recent
dengu
infect
detect
fourfold
igg
igm
increas
antibodi
seroconvers
pair
sera
consid
confirmatori
infect
depend
time
collect
test
viru
rnaantigen
detect
serolog
studi
diagnosi
acut
phase
ill
allow
earli
case
diagnosi
may
import
case
manag
clinic
sampl
collect
earli
possibl
prefer
first
day
fever
onset
tool
avail
earli
diagnosi
includ
molecular
diagnosi
revers
transcriptasepolymeras
chain
reaction
rtpcr
realtim
rtpcr
allow
confirm
infect
serotyp
identif
well
detect
acut
sampl
also
use
viru
isol
denv
rna
extract
serum
plasma
well
whole
blood
wb
blood
leukocyt
fresh
paraffinembed
tissu
mosquito
etc
klungthong
et
al
wang
et
al
storag
hour
specimen
kept
c
longer
storag
sampl
frozen
c
c
liquid
nitrogen
repeat
cycl
avoid
rna
virus
wb
sampl
also
spot
onto
filter
paper
viral
rna
detect
week
even
month
prado
et
al
nest
rtpcr
use
univers
dengu
primer
target
conserv
cprm
region
denv
genom
initi
revers
transcript
amplif
step
follow
nest
pcr
amplif
serotypespecif
lanciotti
et
al
nucleic
acid
sequencebas
amplif
assay
singlestep
isotherm
rnaspecif
amplif
assay
requir
thermal
cycl
instrument
jittmittraphap
et
al
wu
et
al
reversetranscript
loopmedi
isotherm
amplif
assay
base
principl
strand
displac
reaction
stem
loop
structur
amplifi
target
isotherm
condit
well
lau
et
al
sahni
et
al
recent
technolog
use
mass
spectrometri
led
develop
power
system
provid
rapid
discrimin
biolog
compon
complex
mixtur
gijavanekar
et
al
voge
et
al
fig
immunohistochem
method
use
crossreact
polyclon
typespecif
mab
viral
structur
antigen
miagostovich
et
al
ns
protein
balsiti
et
al
antibodi
conjug
fluorescein
boonpucknavig
et
al
peroxidas
waterman
monath
alkalin
phosphatas
hall
et
al
exist
cellassoci
cell
surfac
extracellular
form
amount
serum
shown
directli
correl
viremia
librati
et
al
concentr
plasma
highest
acut
phase
infect
day
day
onset
fever
decreas
usual
detect
day
duyen
et
al
dengu
viremia
correl
fever
onset
peak
level
day
fever
period
viremia
well
diminish
coincid
antibodi
develop
serolog
method
choic
late
acut
convalesc
diagnosi
specif
igm
detect
well
high
level
specif
igg
monoserum
allow
confirm
probabl
recent
infect
igm
andor
igg
seroconvers
fourfold
increas
igg
titer
pair
sera
allow
infect
confirm
gubler
humor
immun
dengu
respons
character
product
antidengu
igm
igg
antibodi
igm
titer
primari
infect
significantli
higher
secondari
infect
gubler
current
igm
antibodi
captur
elisa
serum
sampl
collect
day
fever
onset
constitut
import
method
serolog
dengu
diagnosi
recent
infect
wide
appli
dengu
surveil
hi
test
consid
gold
standard
classifi
case
primari
secondari
infect
use
pair
sera
howev
timeconsum
difficulti
obtain
second
serum
sampl
elisa
often
chosen
lukman
et
al
peopl
suffer
primari
dengu
infect
specif
igg
antibodi
increas
slowli
day
fever
onset
highest
valu
figur
laboratori
diagnosi
dengu
sourc
adapt
guzman
mg
gubler
dj
izquierdo
martinez
e
halstead
sb
dengu
infect
nat
rev
di
primer
day
later
antibodi
titer
declin
low
level
detect
lifetim
cours
secondari
infect
igg
antibodi
rise
earli
infect
remain
high
level
sever
week
month
declin
later
high
level
igg
antibodi
acut
phase
ill
allow
presumpt
diagnosi
igg
seroconvers
fourfold
increas
titer
criterion
dengu
diagnosi
inni
et
al
appli
igm
igg
captur
elisa
detect
immunoglobulin
defin
primari
case
optic
densiti
ratio
igmigg
secondari
dengu
infect
ratio
kuno
et
al
use
indirect
elisa
report
igmigg
ratio
primari
infect
secondari
infect
assay
use
detect
past
denv
infect
hi
igg
elisa
vazquez
et
al
neutral
assay
detect
denv
neutral
antibodi
alvarez
et
al
denv
among
difficult
arbovirus
isol
viru
isol
consid
gold
standard
dengu
diagnosi
perform
laboratori
adequ
infrastructur
technic
expertis
virus
may
recov
serum
plasma
peripher
mononuclear
cell
tissu
collect
autopsi
inoculum
consist
ml
undilut
dilut
sampl
cultur
medium
phosphat
buffer
salin
pb
plu
antibiot
fetal
calf
serum
anim
observ
least
week
rapid
identif
achiev
indirect
immunofluoresc
assay
use
dengu
hyperimmun
ascit
fluid
specif
dengu
mab
rtpcr
neutral
assay
mammalian
cell
line
develop
mammalian
cell
line
vero
llcmk
introduc
denv
isol
cell
line
low
sensit
wildtyp
virus
result
use
routin
denv
isol
although
use
quantit
plaqu
assay
use
solid
semisolid
overlay
mosquito
inocul
intrathorac
inocul
adult
mosquito
open
new
sensit
way
denv
isol
addit
method
inocul
mosquito
larva
develop
mosquito
speci
use
includ
aegypti
albopictu
toxorhynchit
splenden
toxorhynchit
amboinensi
gubler
et
al
mosquito
cell
cultur
mosquito
cell
line
develop
provid
sensit
system
denv
isol
three
cell
line
commonli
use
aed
pseudoscutellari
albopictu
amboinensi
although
sensit
cell
line
wide
use
identif
also
done
plaqu
reduct
neutralis
assay
prnt
rtpcr
virus
may
also
identifi
use
serotypespecif
mab
indirect
immunofluoresc
test
antigen
captur
enzym
link
immunosorb
assay
elisa
use
absenc
fluoresc
microscop
recent
flow
cytometri
well
detect
employ
denv
identif
jarman
et
al
kao
et
al
manag
suspect
dengu
patient
depend
clinic
ill
three
phase
febril
critic
leakag
convalesc
convalesc
phase
divid
earli
hour
shock
hour
leakag
late
convalesc
hour
shock
hour
leakag
three
latter
diseas
manifest
dhf
dhf
grade
ii
dss
dhf
grade
iii
iv
expand
dengu
syndrom
consid
sever
may
lead
complic
death
appropri
time
manag
dhf
dss
patient
differ
df
patient
plasma
leakag
critic
phase
halstead
lum
percentag
dhfdss
patient
also
minim
compar
virallik
ill
df
patient
import
clinicianhealthcar
personnel
diagnos
properli
manag
patient
order
prevent
shock
sever
ill
complic
death
manag
patient
febril
phase
mostli
symptomat
support
treatment
dengu
patient
usual
high
sustain
fever
rang
day
mean
durat
day
common
sign
symptom
sever
headach
retroorbit
pain
bodi
ach
myalgia
arthralgiajoint
pain
minor
bleed
manifest
petechia
epistaxi
gum
bleed
coffeeground
vomit
hematemesi
melena
commonli
found
hemoglobinuria
uncommon
especi
thalassemia
hemoglobinopathi
defici
patient
rash
erythemat
maculopapular
petechi
commonli
observ
especi
adult
patient
malais
poor
appetit
nauseavomit
common
nonspecif
sign
symptom
tourniquet
test
help
diagnos
dhf
dss
way
test
follow
method
blood
pressur
measur
use
appropri
cuff
size
cuff
pressur
increas
half
way
systol
diastol
pressur
minut
releas
minut
normal
skin
circul
observ
result
read
test
consid
posit
petechiaemm
gubler
case
antipyret
paracetamol
recommend
reduc
height
fever
children
adult
aspirin
nsaid
contraind
antiemet
may
given
patient
nauseavomit
support
symptomat
medicin
may
given
accord
clinic
sign
symptom
exampl
anticonvuls
proton
pump
inhibitor
antibiot
indic
associ
bacteri
infect
prevent
paracetamol
overdos
hepatotox
tepid
spong
use
reduc
temperatur
kalayanarooj
follow
indic
shock
impend
shock
narrow
puls
pressur
mmhg
hypotens
commonli
observ
patient
may
present
clinic
sign
shock
rapid
weak
puls
delay
capillari
refil
time
second
coldclammi
skin
skin
mottl
normal
blood
pressur
rise
hct
thrombocytopenia
leukopenia
andor
thrombocytopenia
poor
appetit
clinic
deterior
signific
bleed
defervesc
indic
hospit
kalayanarooj
detect
earli
plasma
leakag
volum
replac
indic
principl
volum
replac
dhfdss
patient
give
minim
amount
maintain
effect
circul
intravascular
volum
intraven
fluid
similar
plasma
lost
pleural
periton
space
exampl
normal
salin
solut
nss
lactat
ringer
solut
acet
ringer
total
volum
replac
critic
period
mainten
deficit
l
adult
estim
total
durat
hour
intraven
fluid
given
patient
enter
critic
period
colloid
solut
use
dhfdss
patient
sign
fluid
overload
colloid
solut
use
plasma
expand
nss
six
percent
hetastarch
voluven
may
use
instead
avail
kalayanarooj
bloodblood
compon
transfus
wb
prefer
avail
plasma
littl
role
treatment
uncompl
dhfdss
hct
blood
transfus
import
measur
manag
followup
assess
degre
bleed
blood
usual
transfus
rate
mlkgh
platelet
transfus
indic
patient
signific
bleed
without
clinic
bleed
valu
platelet
transfus
prophylaxi
children
regardless
low
platelet
count
fallen
prophylaxi
platelet
transfus
may
given
platelet
count
cellsmm
sign
recoveri
case
return
appetit
improv
gener
condit
vital
sign
stabl
hct
return
baselin
level
wbc
return
normal
platelet
count
return
normal
within
day
major
case
increas
urin
output
observ
manag
complic
aris
result
dhfdss
may
done
per
exist
protocol
gubler
littl
effect
vector
control
mani
dengueendem
countri
even
robust
program
implement
diseas
remain
ongo
risk
vector
control
tool
limit
number
efficaci
need
logist
challeng
associ
insecticid
applic
adulticid
larvicid
primari
tool
use
vector
control
result
need
agent
come
direct
contact
target
vector
larg
urban
set
scale
time
applic
impract
especi
resourc
limit
furthermor
mani
protocol
show
benefit
diseas
control
ineffect
effort
due
part
insuffici
monitor
lack
welldesign
program
exacerb
rise
level
insecticid
resist
communitybas
sourc
reduct
treat
mosquito
breed
site
tri
number
locat
almuhandi
hunter
ballengerbrown
elder
erlang
et
al
howev
even
sitespecif
communitybas
campaign
limit
strategi
requir
educ
local
peopl
resourceintens
educ
need
reach
larg
number
peopl
necessari
wage
effect
campaign
communitybas
campaign
struggl
campaign
fatigu
follow
method
indic
use
surveil
dengu
vector
contain
index
percentag
waterhold
contain
posit
aegypti
larva
pupa
hous
premis
index
percentag
hous
posit
contain
aegypti
larva
pupa
breteau
index
number
contain
posit
aegypti
larva
pupa
per
hous
collect
egg
ovitrap
ovitrap
small
contain
set
field
collect
mosquito
egg
collect
adult
use
devic
batterypow
backpack
aspir
develop
american
biophys
corpor
standard
profession
light
trap
omnidirect
fayprinc
trap
without
co
center
diseas
control
prevent
cdc
wilton
trap
bg
sentinel
trap
contain
survey
use
measur
impact
sourc
reduct
effort
classic
sourc
reductionth
elimin
breed
sitesi
conduct
train
inspector
expert
supervis
highli
labori
ineffect
control
larva
use
follow
method
use
kerosen
diesel
oil
similar
product
kill
larva
pupa
penetr
tracheal
system
prevent
respir
monomolecular
film
amphoter
surfact
natur
soya
lecithin
synthet
repeatedli
surfac
put
control
method
russel
insecticid
ddt
effect
aegypti
larva
low
ppm
exampl
initi
success
follow
failur
remark
success
obtain
america
perifoc
treatment
suspens
ddt
appli
insid
outsid
potenti
breed
site
speci
could
longer
found
argentina
bolivia
brazil
british
guiana
chile
nearli
colombia
ecuador
french
guiana
mexico
paraguay
peru
uruguay
central
american
countri
declar
fulli
erad
countri
america
mediterranean
countri
hope
perman
erad
began
fade
howev
rapid
appear
resist
ddt
organochlorin
insecticid
resist
becam
major
problem
organophosphor
larvicid
particularli
temepho
abat
adopt
altern
temepho
methopren
synthet
compound
interfer
insect
metamorphosi
bti
mosquitospecif
guttox
protein
suspens
deriv
bacterium
bacillu
thuringiensi
serotyp
numer
larvicid
plant
extract
identifi
laboratori
giatropoulo
et
al
kovendan
et
al
kovendan
et
al
mahesh
kumar
et
al
concept
use
live
predat
kill
aegypti
attract
although
mani
organ
studi
routin
use
larvivor
fish
use
mani
year
cistern
larg
contain
wu
et
al
control
adult
achiev
use
residu
insecticid
insecticid
chemic
stabl
appli
residu
surfac
onto
mosquito
alight
transient
contact
residu
may
suffici
kill
suscept
insect
fog
aerosol
treatment
use
insecticid
aerosol
wide
use
mosquito
control
gener
accept
mosquito
must
flight
collid
enough
particl
kill
reason
aerosol
effect
particl
airborn
short
time
period
hay
et
al
ultralow
volum
ulv
aerosol
concentr
insecticid
gener
activ
ingredi
usual
refer
ulv
quantiti
liquid
dispens
littl
mlha
indoor
space
spray
low
volum
ulv
aerosol
effect
appli
indoor
space
spray
adult
aegypti
highli
endophil
lofgren
protect
water
storag
contain
elimin
breed
sourc
reliabl
water
suppli
elimin
need
store
water
mani
commun
storag
cultur
habit
reinforc
failur
pipe
suppli
intermitt
use
store
water
enhanc
mosquito
product
vessel
accumul
leav
litter
sourc
larval
nutrit
person
protect
maintain
use
screen
bed
net
mosquito
repel
antimosquito
sound
devic
failur
control
measur
vector
control
agenc
need
new
afford
efficaci
tool
safe
peopl
environ
ideal
tool
scalabl
small
villag
larg
citi
social
accept
econom
polit
sustain
furthermor
compat
current
develop
control
tool
includ
vaccin
antivir
drug
new
insecticid
geneticbas
strategi
target
vector
mosquito
potenti
fill
need
pois
contribut
futur
vector
control
effort
alphey
et
al
wildersmith
et
al
genet
strategi
base
wide
accept
theori
disrupt
vector
phase
pathogen
life
cycl
reduc
elimin
transmiss
human
disrupt
achiev
elimin
reduc
mosquito
densiti
transmiss
threshold
make
mosquito
refractori
viru
infect
novel
strategi
develop
base
genet
engin
strain
mosquito
design
featur
maxim
util
safeti
profil
alphey
et
al
strategi
design
resili
immigr
wild
mosquito
origin
tempor
spatial
other
potenti
lower
popul
densiti
transmiss
threshold
one
vectorborn
pathogen
geneticbas
tool
offer
access
mosquito
breed
site
would
otherwis
inaccess
cryptic
use
convent
tool
genet
approach
principl
safer
vector
control
strategi
employ
insecticid
strain
design
lower
minim
vector
compet
known
pathogen
transmit
target
speci
increas
insecticid
suscept
aksoy
et
al
engin
strain
speciesspecif
aegypti
albopictu
invas
speci
throughout
region
world
prey
upon
opportunist
deploy
strategi
anticip
neglig
impact
ecosystem
adopt
strategi
requir
sitespecif
risk
assess
prior
releas
monitor
surveil
follow
releas
success
genet
strategi
afford
meaning
impact
dengu
transmiss
allen
et
al
sinkin
gould
strategi
impact
field
properti
combin
follow
selflimit
popul
suppressionperiod
releas
genet
engin
mosquito
suppress
popul
size
follow
elimin
engin
insect
cessat
releas
selfsustain
popul
suppressionfew
period
releas
need
suppress
popul
size
selflimit
popul
replacementelimin
abil
mosquito
transmit
viru
selfsustain
popul
replacementelimin
abil
mosquito
transmit
viru
current
absenc
antivir
dengu
trigger
much
research
field
dengu
drug
discoveri
mani
hypothes
treatment
effect
antivir
within
hour
onset
diseas
may
lead
rapid
reduct
viral
load
limit
develop
sever
dengu
may
also
lead
reduc
diseas
morbid
df
patient
well
reduc
transmiss
experi
reveal
level
proinflammatori
cytokin
extent
splenomegali
also
reduc
drug
treatment
human
clinic
trial
patient
acut
dengu
conduct
chloroquin
tricou
et
al
balapiravir
nguyen
et
al
one
approach
develop
drug
inhibit
modul
host
target
lead
trigger
inflamm
cascad
given
complex
dengu
diseas
pathogenesi
critic
establish
set
characterist
ideal
drug
treatment
df
possess
briefli
effect
drug
must
activ
four
dengu
serotyp
oral
drug
least
expens
form
manufactur
distribut
import
consider
diseas
endem
develop
countri
drug
ideal
would
effect
day
dose
acut
dengu
dose
frequenc
often
three
time
day
need
maintain
drug
level
minim
effect
concentr
would
accept
viral
process
target
antivir
includ
entryfus
inhibitor
translationpolyprotein
process
inhibitor
replic
inhibitor
packagingviru
matur
inhibitor
nobl
et
al
entri
inhibitor
inhibitor
bind
directli
viral
e
protein
schmidt
et
al
schmidt
et
al
interfer
step
viral
host
membran
fusion
use
effect
block
viral
entri
similarli
peptidebas
inhibitor
target
stem
region
e
protein
therapeut
antibodi
bind
e
domain
iii
diii
part
e
ectodomain
neutral
viru
cellbas
infect
assay
mab
e
protein
domain
iii
potent
neutral
dengu
infect
either
serotypespecif
crossreact
beltramello
et
al
follow
entri
cell
dengu
viral
mrna
recogn
host
translat
machineri
produc
polyprotein
process
matur
structur
ns
protein
action
host
proteas
resid
er
lumen
viral
proteas
cytoplasm
activ
tetrapeptid
tripeptid
inhibitor
synthes
probe
dynam
denv
proteas
activ
site
differ
function
group
compet
substrat
activ
site
serinetrap
inhibitor
contain
either
boron
acid
trifluoromethylketon
aldehyd
electrophil
warhead
schuller
et
al
show
potent
proteas
inhibitor
activ
proteas
well
flavivir
proteas
thu
demonstr
pandengu
panflavivir
proteas
inhibitor
develop
chu
et
al
dwivedi
et
al
pelliccia
et
al
soar
et
al
tan
et
al
wu
et
al
addit
target
polyprotein
process
shown
specif
translat
inhibitor
develop
peptideconjug
phosphorodiamid
morpholino
oligom
specif
inhibit
viral
rna
translat
viral
rna
synthesi
mimick
sl
sl
respect
investig
holden
et
al
replic
inhibitor
target
helicas
methyl
transferas
rdrp
consid
mani
vitro
studi
prove
efficaci
abdelmagid
da
costa
et
al
pelliccia
et
al
yeo
et
al
viral
packag
inhibitor
interact
capsid
rna
encapsid
allud
prevent
import
interact
could
lead
discoveri
new
antivir
compound
also
furin
inhibitor
provid
strategi
inhibit
viru
replic
potent
inhibitor
may
broad
act
antivir
pursu
becker
et
al
potenti
use
safe
effect
dengu
vaccin
attract
dengu
control
addit
vector
control
even
partial
effect
use
dengu
vaccin
could
highli
benefici
blunt
dengu
epidem
increas
populationlevel
immun
level
vector
control
could
effect
halstead
deen
dengu
vaccin
could
benefici
individuallevel
effect
reduc
probabl
infect
given
exposur
infect
mosquito
vaccin
efficaci
suscept
infect
reduc
probabl
clinic
diseas
given
infect
probabl
sever
diseas
diseas
progress
reduc
probabl
infect
vaccin
person
transmit
viru
mosquito
bite
direct
transmiss
addit
increas
vaccin
coverag
popul
vaccin
could
reduc
overal
transmiss
entir
commun
even
unvaccin
peopl
thu
indirect
herd
effect
individuallevel
communitylevel
vaccin
effect
need
taken
account
assess
potenti
effect
impact
dengu
vaccin
halstead
potenti
vaccin
must
provid
delic
balanc
level
immunogen
evok
attenu
denv
pathogen
immunogen
induc
vaccin
level
neutral
antibodi
produc
high
enough
provid
complet
protect
four
serotyp
also
suffici
attenu
caus
unaccept
pathogen
underattenu
fail
induc
effect
immun
respons
overattenu
halstead
aguiar
dengu
vaccin
develop
develop
discuss
denv
vaccin
base
vaccin
viru
chimera
chimer
yellow
fever
viru
attenu
cyd
oper
hypothesi
attenu
characterist
yf
vaccin
viru
impart
similar
attenu
attribut
chimera
guirakhoo
et
al
chimer
virus
replic
yf
rna
polymeras
cyd
tetraval
vaccin
produc
combin
four
cyd
virus
singl
vaccin
prepar
vaccin
contain
adjuv
preserv
us
cdc
develop
tetraval
chimer
dengu
vaccin
splice
prm
e
gene
attenu
ns
rna
success
attenu
tetraval
vaccin
candid
undergon
preclin
test
mice
nonhuman
primat
compar
intraderm
subcutan
rout
deliveri
intraderm
deliveri
tetraval
prepar
denvax
pfu
per
denvtyp
produc
superior
immun
respons
cynamolg
monkey
osorio
et
al
b
develop
vaccin
contain
molecularli
attenu
virus
mutant
transcrib
recombin
cdna
delet
utr
produc
lower
viremia
slightli
decreas
neutral
antibodi
respons
compar
wildtyp
bray
et
al
similar
construct
made
evalu
anim
model
found
attenu
immunogen
make
recombin
r
prm
e
structur
protein
candid
vaccin
ngc
yet
anoth
approach
use
capsiddelet
wnv
vector
produc
denv
pseudoinfecti
deriv
suzuki
et
al
denvwnv
chimera
expect
retain
wildtyp
wnv
attribut
high
replic
effici
enhanc
product
potenti
approach
anoth
vaccin
candid
made
contain
membran
precursor
envelop
e
gene
insert
delet
utr
nation
institut
health
nih
chosen
gener
tetraval
dengu
vaccin
either
separ
introduc
terminu
chang
four
denv
make
structur
gene
chimera
includ
four
set
dengu
antigen
use
combin
approach
investig
center
biolog
evalu
research
us
fda
creat
chimer
viru
combin
termin
stem
loop
structur
wnv
viru
grew
normal
mammalian
llcmk
cell
sever
restrict
growth
insect
cell
design
mutant
f
mutf
rhesu
monkey
immun
respons
similar
wildtyp
viru
li
et
al
yang
et
al
unit
state
arm
forc
epidemiolog
board
initi
cooper
scientif
effort
develop
vaccin
four
denv
worker
depart
tropic
medicin
medic
microbiolog
univers
hawaii
medic
school
anticip
effort
screen
tissu
culturepassag
wildtyp
mousepassag
cell
system
use
propag
viral
vaccin
licens
use
unit
state
includ
continu
human
embryo
lung
primari
chick
duck
embryo
fibroblast
primari
rabbit
kidney
cell
primari
dog
pdk
kidney
cell
primari
african
green
monkey
kidney
cell
serial
passag
differ
wildtyp
denv
result
phenotyp
chang
phenotyp
chang
use
success
identifi
human
dengu
vaccin
candid
mahidol
univers
vaccin
introduc
human
trial
human
volunt
thailand
develop
classic
df
result
led
abandon
develop
mahidol
lav
goh
et
al
huang
et
al
rabablert
yoksan
advent
genet
engin
mani
attempt
made
develop
vaccin
insert
gene
structur
protein
replic
carrier
viru
commonli
use
vector
earli
era
vaccinia
viru
deubel
et
al
men
et
al
technolog
gene
code
amino
acid
envelop
domain
iii
ediii
fuse
amino
acid
ectodomain
membran
protein
ectom
insert
genom
schwarz
strain
measl
vaccin
brandler
et
al
brandler
et
al
least
two
laboratori
develop
secondgener
adenoviru
complex
vector
express
present
dengu
antigen
two
construct
develop
one
prm
e
gene
gene
vaccin
mix
given
larg
group
rhesu
monkey
twenti
percent
anim
rais
tetravalentneutr
antibodi
follow
one
dose
develop
hightit
neutral
antibodi
boost
second
dose
month
later
challeng
live
month
anim
protect
moder
protect
challeng
holman
et
al
raviprakash
et
al
univers
north
carolina
develop
vaccin
denv
e
protein
produc
venezuelan
enceph
viru
replicon
vrp
gene
cassett
encod
envelop
protein
e
protein
prm
e
mouseadapt
strain
ngc
clone
vrp
program
proper
vitro
express
process
e
protein
infect
vero
cell
immun
balbc
mice
result
high
level
denvspecif
serum
igg
signific
level
neutral
antibodi
khalil
et
al
white
et
al
white
et
al
walter
reed
armi
institut
research
also
develop
tetraval
liveattenu
dengu
vaccin
base
serial
passag
wildtyp
denv
pdk
cell
among
select
passag
level
seroconvers
rate
singl
dose
respect
kanesathasan
et
al
tand
bcell
epitop
map
denv
structur
protein
ediii
ns
protein
kuran
et
al
right
combin
epitop
express
protein
subunit
vaccin
could
basi
effect
safe
vaccin
moder
cost
structur
ns
denv
protein
produc
adequ
amount
mani
express
system
includ
escherichia
coli
simmon
et
al
baculoviru
spodoptera
frugiperda
insect
cell
drosophila
cell
velz
et
al
yeast
tan
et
al
vaccinia
viru
men
et
al
dna
vaccin
consist
plasmid
plasmid
contain
dengu
gene
reproduc
high
copi
number
bacteria
e
coli
whalen
plasmid
contain
eukaryot
promot
termin
sequenc
drive
transcript
vaccin
recipi
transcrib
rna
translat
produc
protein
process
present
immun
system
context
mhc
molecul
addit
gene
intracellular
traffick
immunostimulatori
sequenc
ad
plasmid
target
organ
immun
system
recogn
express
antigen
gener
antibodi
andor
cellmedi
immun
respons
dnabas
vaccin
construct
modifi
without
need
subsequ
viabil
requir
work
infecti
clone
dna
vaccin
afford
numer
advantag
convent
vaccin
includ
eas
product
stabil
transport
room
temperatur
provid
possibl
immun
multipl
pathogen
singl
vaccin
worker
us
naval
medic
research
institut
evalu
two
eukaryot
plasmid
express
vector
pkcmvintpolyli
express
prm
protein
e
protein
new
guinea
c
strain
construct
induc
neutral
antibodi
mice
kochel
et
al
variou
improv
origin
construct
made
anim
trial
underway
evalu
immunogen
efficaci
